Article info

other Versions

PDF
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment

Authors

  1. Correspondence to Dr Charlotta Hedner, Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden; charlotta.hedner{at}med.lu.se
View Full Text

Citation

Hedner C, Borg D, Nodin B, et al
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment

Publication history

  • Received September 5, 2017
  • Revised October 23, 2017
  • Accepted October 25, 2017
  • First published November 14, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.